“In vivo anticancer activities of Ni (II)-Benzoin thiosemicarbazone complex [Ni(BTSC)2] against ehrlich ascites carcinoma cells”, J bio-sci., vol. 23, pp. 77–88, Jul. 2018, doi: 10.3329/jbs.v23i0.37470.